For weeks, they’d been having furtive discussions about whether Sam Altman, OpenAI’s C.E.O., and Greg Brockman, his second-in ...
Advances in iPSC technology and in vivo reprogramming are expanding the possibilities for cell therapy. Explore the science ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results